Nuvalent (NUVL) Total Non-Current Liabilities (2024 - 2026)

Nuvalent (NUVL) reported Total Non-Current Liabilities of $156.8 million for Q1 2026, up 66.07% on a YoY basis from $94.4 million in Q1 2025, and down 4.59% quarter-over-quarter from $164.3 million in Q4 2025.

Nuvalent (NUVL) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

Nuvalent has reported Total Non-Current Liabilities for 3 years, with the latest figure at $156.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 66.07% year-over-year to $156.8 million; the trailing twelve-month figure through Mar 2026 stood at $156.8 million (up 66.07% YoY), and the FY2025 full-year result was $164.3 million, up 128.36% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $156.8 million, down from $164.3 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $164.3 million in Q4 2025, with the low at $51.1 million in Q3 2024.
  • Historically, Total Non-Current Liabilities has averaged $110.5 million across 3 years, with a median of $100.6 million in 2025.
  • Annual changes were most pronounced in 2025 — Total Non-Current Liabilities surged 162.79% — and 2026, when it jumped 66.07%.
  • Nuvalent's Total Non-Current Liabilities stood at $72.0 million in 2024, then surged by 128.36% to $164.3 million in 2025, then retreated by 4.59% to $156.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $156.8 million (Q1 2026), $164.3 million (Q4 2025), and $134.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 42,980.09
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 11.03 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.71 Bn 91.71 Bn - 64.76 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - 156.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 156.78 Mn
Dec 31, 2025 164.33 Mn
Sep 30, 2025 134.37 Mn
Jun 30, 2025 100.56 Mn
Mar 31, 2025 94.40 Mn
Dec 31, 2024 71.96 Mn
Sep 30, 2024 51.13 Mn